Staged thrombolysis and percutaneous transluminal coronary angioplasty for unstable and postinfarction angina.

Abstract

The precise timing of intravenous thrombolysis and coronary angioplasty continues to be evaluated for patients who have coronary thrombosis and unstable angina or postinfarction angina. Coronary angioplasty is effective for these patients but is associated with thromboembolic coronary occlusion in 24% to 29% of cases. After adjunctive intravenous thrombolysis and oral antiplatelet therapy to improve the success rate and to decrease the risk of acute occlusion, deferred angioplasty was successful in three patients with intracoronary thrombus and unstable angina or postinfarction angina. Staged thrombolysis and deferred angioplasty is feasible for selected patients with these acute coronary syndromes.

• Authors: D V Hurley, D R Bresnahan, D R Holmes Jr
• Journal: Catheterization and cardiovascular diagnosis (Cathet Cardiovasc Diagn) Vol. 18 Issue 2 Pg. 67-72 (Oct 1989) ISSN: 0098-6569 [Print] United States
• PMID: 2529036 (Publication Type: Case Reports, Journal Article)

Chemical References

• Fibrinolytic Agents

Topics

• Adult
• Angina Pectoris (drug therapy, etiology, therapy)
• Angioplasty, Balloon
• Coronary Disease (therapy)
• Coronary Thrombosis (complications, drug therapy, therapy)
• Fibrinolytic Agents (therapeutic use)
• Humans
• Male
• Middle Aged